Patents by Inventor Andree Rothermel

Andree Rothermel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10705089
    Abstract: The present invention relates to methods and kits for the diagnosis, prognosis and/or monitoring of cancer in a patient. The present invention further relates to isolated peptides, panels of isolated peptides and diagnostic devices.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: July 7, 2020
    Assignees: BioNTech Disgnostics GmbH, TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
    Inventors: Rainer Hipfel, Clara Werner, Andree Rothermel, Ugur Sahin, Yvonne Kuhne
  • Patent number: 10670576
    Abstract: The present invention refers to a device for measuring impedance in organotypic tissue comprising at least one recording chamber with a liquid permeable membrane supporting the organotypic tissue, at least one bottom electrode and at least one top electrode, wherein the liquid permeable membrane divides the recording chamber into a top chamber and a bottom chamber, wherein at least the bottom chamber contains culture medium for the organotypic tissue, and the bottom electrode(s) is/are located in the bottom chamber and the top electrode(s) is/are located in the top chamber, and wherein the organotypic tissue is located between the bottom electrode(s) and the top electrode(s). The present invention also refers to the use of the device according to the present invention for measuring impedance in organotypic tissue.
    Type: Grant
    Filed: January 18, 2017
    Date of Patent: June 2, 2020
    Assignee: Universität Leipzig
    Inventors: Andrea Robitzki, Andrée Rothermel, Heinz-Georg Jahnke, Ina Sternberger, Frank Striggow, Till Mack
  • Publication number: 20190033316
    Abstract: The present invention relates to methods and kits for the diagnosis, prognosis and/or monitoring of cancer in a patient. The present invention further relates to isolated peptides, panels of isolated peptides and diagnostic devices.
    Type: Application
    Filed: April 15, 2015
    Publication date: January 31, 2019
    Inventors: Rainer Hipfel, Clara Werner, Andree Rothermel, Ugur Sahin, Yvonne Kuhne
  • Publication number: 20170191980
    Abstract: The present invention refers to a device for measuring impedance in organotypic tissue comprising at least one recording chamber with a liquid permeable membrane supporting the organotypic tissue, at least one bottom electrode and at least one top electrode, wherein the liquid permeable membrane divides the recording chamber into a top chamber and a bottom chamber, wherein at least the bottom chamber contains culture medium for the organotypic tissue, and the bottom electrode(s) is/are located in the bottom chamber and the top electrode(s) is/are located in the top chamber, and wherein the organotypic tissue is located between the bottom electrode(s) and the top electrode(s). The present invention also refers to the use of the device according to the present invention for measuring impedance in organotypic tissue.
    Type: Application
    Filed: January 18, 2017
    Publication date: July 6, 2017
    Applicant: Universität Leipzig
    Inventors: Andrea ROBITZKI, Andrée Rothermel, Heinz-Georg Jahnke, Ina Sternberger, Frank Striggow, Till Mack
  • Publication number: 20090247898
    Abstract: The present invention refers to a device for measuring impedance in organotypic tissue comprising at least one recording chamber with a liquid permeable membrane supporting the organotypic tissue, at least one bottom electrode and at least one top electrode, wherein the liquid permeable membrane divides the recording chamber into a top chamber and a bottom chamber, wherein at least the bottom chamber contains culture medium for the organotypic tissue, and the bottom electrode(s) is/are located in the bottom chamber and the top electrode(s) is/are located in the top chamber, and wherein the organotypic tissue is located between the bottom electrode(s) and the top electrode(s). The present invention also refers to the use of the device according to the present invention for measuring impedance in organotypic tissue.
    Type: Application
    Filed: February 24, 2009
    Publication date: October 1, 2009
    Applicant: KeyNeurotek Pharmaceuticals AG
    Inventors: Andrea ROBITZKI, Andree Rothermel, Heinz-Georg Jahnke, Ina Sternberger, Frank Striggow, Till Mack